Living donor pathway
A suitable living donor may donate a portion of the liver after comprehensive medical and other required evaluation.
A living-donor liver transplant uses a portion of a suitable living donor’s liver for transplantation into the recipient after donor and recipient assessment. The pathway is considered when the clinical team determines that living donation is appropriate.
A suitable living donor may donate a portion of the liver after comprehensive medical and other required evaluation.
The recipient is assessed for transplant suitability, disease severity and the appropriate transplant pathway.
Living donation provides no medical benefit to the donor; donor safety and suitability are fundamental to the pathway.
Blood group and other donor-recipient factors are assessed. If direct compatibility is a concern, a specialised pathway may be considered in selected cases.
A living-donor pathway may be considered for selected patients whose liver disease or other transplant indication warrants transplantation and for whom an appropriate living donor can be evaluated. Suitability is determined by the transplant team.
Explain that selected patients may be assessed for transplantation.
Explain that some severe cases require urgent specialist assessment.
Link to the dedicated liver-transplant-for-cancer page; avoid implying every liver cancer patient is eligible.
Explain only at a high level and keep suitability individualized.
The supplied transplant materials support a high-level evaluation covering recipient fitness, donor safety, blood group, anatomy, graft considerations, donor liver health and the applicable transplant pathway. The exact Ruby Hall work-up should be inserted only after clinician confirmation.
Diagnosis, disease severity, current clinical condition and transplant suitability.
Independent assessment focused on whether donation is medically appropriate and safe.
Record blood-group compatibility assessment; link to ABOIncompatible & Swap page where relevant.
Assessment of donor and recipient anatomy relevant to planning.
Assess whether the proposed donor graft is appropriate; do not publish fixed thresholds unless approved.
Additional investigations are arranged according to the clinical situation.
review diagnosis, records and transplant indication.
assess disease severity and overall suitability.
assess donor safety and suitability independently.
review blood group, anatomy, graft considerations and pathway
discuss suitability, next steps and required approvals/arrangements.
recipient monitoring and donor follow-up, with long-term specialist care as required.
Detailed pathway on this page.
Link only when relevant; do not duplicate pediatric content.
Link to deceased-donor and waiting-list pages; allocation rules belong there.
The recipient requires hospital recovery, immunosuppressive medication, graft monitoring and long-term follow-up. Link to the dedicated Liver Transplant Recovery & Long-Term Care and Post-Transplant Nutrition pages. Donor follow-up should be described only to the level approved by Ruby Hall.
MBBS · DNB (General Surgery) · Fellowship in Liver Transplantation, Global Hospital, Chennai
Dr. Manoj Shrivastav is a liver transplant surgeon at Ruby Hall Clinic, Pune, and currently leads the multi-organ transplant programme. He has personally completed over 200 liver transplants in Pune, 100 of them in the past year alone, with a survival rate above 95% and a one-year survival rate of 92% across his transplant series.
He is equipped to handle acute surgical emergencies and trauma across a variety of scenarios, has performed major liver resections for hepatocellular carcinoma and cholangiocarcinoma, and believes a successful transplant depends on excellent teamwork across the entire clinical team — not one surgeon alone.
Meet the TeamA potential living donor must undergo comprehensive assessment to determine medical suitability and donor safety. Exact eligibility criteria should be confirmed with the transplant team.
Not necessarily. Blood-group mismatch may change the pathway and may require specialised assessment.
No. Donor suitability is determined through individual medical and other required evaluation.
The evaluation is focused on donor safety and suitability and may include review of medical condition, blood group, anatomy, liver health and other factors relevant to the pathway.
If a suitable living donor is not available, the patient may be evaluated for the applicable deceased-donor pathway, subject to medical and regulatory requirements.
The recipient requires close post-transplant monitoring and long-term specialist care; donor follow-up is also part of the pathway.
Speak with the Liver Sciences & Multi-Organ Transplant team at Ruby Hall Clinic, Pune. Bring available medical records, imaging,
laboratory reports and previous treatment details where available.